Low impact
Islet Transplantation for Chronic Pancreatitis and Donislecel-jujn for Type 1 Diabetes
Blue Cross & Blue Shield of Mississippi·Identified Jun 20, 2026
HCPCS S2102 is officially defined as "Islet cell tissue transplant from pancreas; allogeneic." HCPCS S2102 is referenced in 1 tracked payer policy change from Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S2102 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.